non-communicable diseases

Lessening the Burden of Non-Communicable Diseases

Blog

Fundamental to Pfizer’s approach in supporting global health is helping to ensure that individuals have the opportunity to lead healthy lives.

The Pfizer Foundation: Reaching Individuals in Need

Multimedia with summary

For nearly 65 years, the Pfizer Foundation has been working to expand health care access for people around the world. The impact of this work is significant and far-reaching, helping underserved individuals from diverse backgrounds in remote corners of the globe.

Call for Solutions by July 31: Submit Initiatives That Address One of Three Global Challenges Through Collaboration

PYXERA Global is Hosting Fall Virtual Event Series on the Youth Skills Gap, Post-Harvest Loss, and Treatable and Preventable NCDs
Press Release

WASHINGTON, July 26, 2017 /3BL Media/ - The time is now to engage partners, begin collaborations, scale solutions, and make progress on solvable problems such as reducing post-harvest loss, bridging youth skills gap and increasing employability, and treating and preventing non-communicable diseases (NCDs). PYXERA Global will host a #GEFlive fall virtual event series on those three solvable problems, starting in September.

The Key to Fighting Chronic Disease in South-East Asia: Young People

More than half the ASEAN region’s 630 million people are under age 30. Harald Nusser, Head of Novartis Social Business, says that to fight the rise of chronic disease in South East Asia we need to inform its youth on the importance of healthy lifestyles.
Article

Preventing the Preventable and Treating the Treatable

The Three Non-Communicable Diseases Collaboration Can Solve
Article

The start of a new year often conjures up hopes of a new you – losing extra pounds, stopping that unhealthy habit, or making changes to enrich life overall. In fact, many of us are already trying to prevent bad health and create solutions for the solvable in ourselves.

Novartis Foundation Dialogue Explores Urban Health Challenges in Africa

More than half the world’s population now lives in urban areas and healthcare services in growing cities are struggling. Experts from around the world are in Cape Town this week to discuss this growing health challenge.
Article

Rapid urbanization in low- and middle-income countries is having a significant impact on the health and wellbeing on the world’s population.  For the first time in history, more than 50% of the world’s population lives in an urban area – and by 2050, it’s estimated that 70% of will be living in towns and cities. Healthcare services in growing cities are struggling, and are already swamped with ongoing challenges like infectious diseases.

Kenya First Country to Launch ‘Novartis Access’, Expanding Affordable Treatment Options Against Chronic Diseases

Program supports Kenyan government on non-communicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country
Summary: 

•    Novartis Access is a first-of-its-kind portfolio of products aimed at increasing access to medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low- and low-middle-income countries
•    Program supports Kenyan government on non-communicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country1
•    Agreements signed with Kenyan government and NGOs include programs to distribute medicines, raise disease awareness and strengthen healthcare system capabilities in key NCDs 

Press Release

•    Novartis Access is a first-of-its-kind portfolio of products aimed at increasing access to medicines against cardiovascular diseases, diabetes, respiratory illnesses and breast cancer in low- and low-middle-income countries
•    Program supports Kenyan government on non-communicable disease (NCD) prevention and control – by 2030, NCDs are expected to cause more than 60% of deaths in the country1
•    Agreements signed with Kenyan government and NGOs include programs to distribute medicines, raise disease awareness and strengthen healthcare system capabilities in key NCDs 

Lilly: The Power of Partnership

By Bart Peterson
Blog
A version of today’s guest blog from our Sr. Vice President of Corporate Affairs, Bart Peterson originally appeared on PharmaPhorum.
 

Lilly Collaborates to Fight NCDs in South Africa

Multimedia with summary

Lilly Collaborates to Fight NCDs in South Africa

by Karen Van der Westhuizen, Communication Manager of Lilly’s Global Health Programs.

The Lilly NCD Partnership is one of Lilly’s flagship corporate responsibility initiatives. Launched in late 2011, the partnership works in four countries (Brazil, India, Mexico and South Africa) to research innovative ways to tackle non-communicable diseases (NCDs),specifically diabetes.

Pages

Subscribe to non-communicable diseases